Energy and Mining Sectors Drive Demand for Water and Wastewater Treatment Equipment in South Africa, Finds Frost & Sullivan

CAPE TOWN, South Africa, August 30, 2010 – Increased demand for energy supplies and the need for regulatory
compliance by mining companies are driving the water and wastewater treatment
equipment market in South Africa.

(Logo: photos.prnewswire.com/prnh/20081117/FSLOGO)
(Logo: www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

New analysis from Frost & Sullivan (www.environmental.frost.com)
South African Water [...]

From the Laboratory to the Reality of Daily Life

Picture is available via epa european pressphoto agency and can be downloaded free of charge at: https://www.presseportal.de/pm/32079

DUDERSTADT, Germany, August 30, 2010 – Christian Kandlbauer, who lost both of his arms in a high
voltage accident, uses a unique development which until recently sounded
almost like science fiction: An arm prosthesis, the first of its kind in [...]

East African Genset Market Poised for High Growth Due to the Power Crisis, Notes Frost & Sullivan

CAPE TOWN, South Africa, August 30, 2010 – The East African region is fraught with seasonal droughts and a
consequent power crisis. This crisis, coupled with an expected rise in
economic growth in the region, is the main driver for growth in the East
African genset market. The sectors that are experiencing significant growth
include, but are not [...]

RusHydro Joins OTCQX

NEW YORK, August 30, 2010 – Pink OTC Markets Inc. (OTCQX: PINK), the financial information and
technology services company that operates the leading electronic quotation
and trading system in the U.S. OTC securities market, today announced that
RusHydro JSC (RTS, MICEX: HYDR; LSE: HYDR; OTCQX: RSHYY), Russia's largest
power-generating company, has chosen to have its American Depositary Receipts
(ADRs) [...]

The Whole Garden World at spoga+gafa 2010 in Cologne

Trends and New Products From Over 2,000 Suppliers From 53 Countries
COLOGNE, Germany, August 30, 2010 – The Cologne Exhibition Centre in full bloom: From 5th to 7th September
2010 spoga+gafa is bringing the market participants from the international
garden and leisure sector together in the cathedral city. At the world's
leading business platform of the year over [...]

ATOLL Study Results With Intravenous Enoxaparin in Acute Heart Attack Managed with Urgent Angioplasty

Composite Primary Endpoint: Risk Reduction of 17% (Non-Statistically Significant ) in Death, Complication of Myocardial Infraction, Procedure Failure or Major Bleeding (p=0.07)

PARIS, August 30, 2010 – Pitie-Salpetriere Hospital, Paris, France, August 30th 2010.
The international ATOLL study sponsored by the Assistance Publique – Hopitaux
de Paris showed that enoxaparin reduced the composite of death, complication
of myocardial [...]

Ballast Nedam Signs Contract for Anholt Offshore Wind Farm

NIEUWEGEIN, The Netherlands, August 30, 2010 – Ballast Nedam has signed a contract with A2SEA A/S for the use of the
Heavy Lift Vessel (HLV) Svanen at the Anholt offshore wind farm in Denmark.
A2SEA is providing the Danish energy company DONG Energy with the vessel for
the installation of the foundations in this wind farm. DONG [...]

Teriflunomide Significantly Reduced Annualized Relapse Rate and was Well Tolerated in MS Patients

First Results From the TEMSO Phase III Trial to be Presented During the ECTRIMS Congress in October 2010

PARIS, August 30, 2010 – Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today
that the investigational once-daily oral drug teriflunomide significantly
reduced annualized relapse rate (ARR) at 2 years versus placebo in patients
with relapsing multiple sclerosis (RMS), thus achieving [...]

Multaq(R) First-line Option in New 2010 ESC Guidelines for the Management of Atrial Fibrillation

PARIS, August 29, 2010 – Sanofi aventis (EURONEXT: SAN and NYSE: SNY) announced today
that the European Society of Cardiology (ESC) 2010 new Guidelines for the
Management of Atrial Fibrillation (AF) have been released and recommend that
Multaq(R) (dronedarone) should be used for maintenance of sinus rhythm as a
first-line treatment option in all patients with paroxysmal and [...]